Physicians can no longer ignore complementary medicine
Because of its occasional dramatic effect in the treatment of androgen-independentprostate cancer, PC-SPES, a mixture of eight Chinese herbs, has awakenedphysician interest in herbal remedies, dietary modifications, vitamins,minerals, and supplements (see related article, page 12). What not so manyyears ago was considered "alternative medicine" has moved steadilyinto the realm of acceptance as indicated by the current terminology, "complementary,or integrated, medicine," and is now beginning to reach the mainstreamof traditional care.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.
Justin B. Ziemba, MD, discusses clinical factors that help identify patients at increased risk for kidney stone recurrence and guide metabolic evaluation.
Adam Sharp, PhD, BM, MRCP, BSc, discusses preliminary safety and efficacy findings from a phase 1/2 study of gedatolisib plus darolutamide in patients with mCRPC.